The News
Telix Pharmaceuticals has announced a research collaboration with University Hospital Essen to explore the prognostic value of AI-enabled PSMA-PET imaging through the PROMISE-PET registry.
Why It Matters
This collaboration signifies a strategic move towards integrating AI in medical imaging, potentially improving patient management and outcomes in prostate cancer diagnostics. The findings could influence future AI applications in healthcare, emphasizing the importance of data-driven decision-making.
Key Evidence
The information is sourced from an official announcement via Globe Newswire, ensuring reliability.
Original Article
aktiencheck
DE source 路 Published Feb 27
https://www.aktiencheck.de/news/Artikel-Telix_Joins_Forces_with_University_Hospital_Essen_on_PROMISE_PET_Optimizing_Patient_Management_through_AI_enabled_PSMA_PET_Imaging-19513995